Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: November 21, 2024

  • Open
    40.98
  • High
    43.38
  • Low
    40.72
  • Close
    41.65
  • Volume
    936,375

Financial ratios

Mar 31, 2024

Activity ratios
Inventory turnover
—
Receivables turnover
—
Payables turnover
11.35
Working capital turnover
0.54
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
—
Number of days of payables
32.17
Fixed asset turnover
283.61
Total asset turnover
0.50
 Liquidity ratios
Current ratio
15.72
Quick ratio
8.08
Cash ratio
8.08
Cash conversion cycle
-32.17
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
1.12
Interest coverage
64.76
 Profitability ratios
Gross profit margin
87.37%
Operating profit margin
47.19%
Pretax margin
52.50%
Net profit margin
51.45%
Operating return on assets (Operating ROA)
23.63%
Return on assets (ROA)
25.76%
Return on total capital
26.53%
Return on equity (ROE)
28.93%